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Cap43 [Cap43 (GenBank access. no.
AF006162) is our designation for this
protein, but it has also been named Drg-1
(GenBank access. no. X92845) (1)] was origi-
nally cloned as a homocysteine-responsive
gene in human endothelial cells (2).
Subsequent studies in our laboratory showed
that Cap43 mRNA was inducible in human
lung cells exposed to nickel and cobalt (3).
The reason for the induction by nickel and
cobalt was because these metals mimicked a
state of hypoxia in cells. Cap43 mRNA was
shown to be induced by hypoxic stress in vir-
tually every cell that has been studied (4).
The dependence of Cap43 on hypoxia was
further investigated in HIF-1α knockout cells
that had lost their ability to induce Cap43 in
response to nickel, cobalt, or hypoxia (4).
Additionally, a computer analysis has found
that there is one HIF-1 binding site in the
promoter and two HIF-1 binding sites in the
3´ untranslated region of Cap43, further sug-
gesting regulation of Cap43 by HIF-1. An
HIF-1 binding site in the 3´ region of the
erythropoietin gene is known to regulate its
transcription (5). Cap43 mRNA was also
shown to be induced by a stressful elevation
of intracellular calcium (6). However, the
function of the Cap43 protein is currently
unknown. The ability of Cap43 to be
induced by homocysteine in human endothe-
lial cells suggested a possible role of Cap43 in
atherosclerotic disease (6). Recent studies
have shown that Cap43 is expressed at lower
levels in colon cancer compared with normal
tissue (1). In another study the expression of
Cap43 was found to be lower in breast and
prostate cancer cells compared with normal
cells (7). However, because expression of this
gene is hormone dependent, the loss of
expression in breast and prostate cancer cells
is most likely due to the loss of hormone
dependency in these cells. We have conﬁrmed
that there are lower levels of expression in
prostatic cancer cells compared with normal
prostate epithelium, but the induction by
hypoxia was signiﬁcantly higher in the more
malignant prostate cancer (8). Here we dis-
cuss the relationship of Cap43 induction by
Ni and hypoxia to its overexpression in
cancer cells.
Materials and Methods
Tumor and normal tissue sections were
obtained from the tumor registry of the
Kaplan Comprehensive Cancer Center.
Tumors and normal tissues were processed
and embedded in paraffin wax. Sections
5µ m thick were cut, deparaffinized using
xylol, and stained with hematoxylin–eosin
(H&E) for histopathological diagnosis. For
immunohistochemical detection, slides were
heated in 1 mM EDTA buffer in a micro-
wave oven, and endogenous peroxide was
blocked with methanol containing 0.35%
H2O2 for 30 min. A rabbit polyclonal anti-
body against Cap43 protein was incubated
with the tissue sections for 2 hr and detected
using routine avidin–biotin horseradish per-
oxidase complex and 3,3´-diaminobenzidine
as the chromogen. Negative controls were
performed with nonimmune sections instead
of primary antibodies. The Cap43 antibody
was made against a 30 amino acid segment
near the C-terminal portion of the protein.
The 30 amino acids consisted of three 10-
amino-acid repeats. The antibody stains only
one protein having the molecular weight of
Cap43 (43,000 Da) in Western blots (see
Figure 6).
Normal and cancerous tissues were also
stained with HIF-1α antibody obtained from
Neo Markers (Union City, CA, USA).
Normal and cancerous tissues were also
stained with the cytochrome P450 1B1
(CYP1B1) antibody obtained from GEN-
TEST Corporation (Woburn, MA, USA).
Cell Lines and Culture Conditions
A549 (human lung cancer), HCT116 (human
colon tumor), and NCI-H69 (human lung
small-cell carcinoma) cells were purchased
from the American Type Culture Collection
(Rockville, MD, USA). Human lung bron-
choepithelial A549 cells were grown in Ham’s
F-12K medium; HCT116 and NCI-H69
were grown in RPMI 1640 supplemented
with 10% fetal bovine serum, 100 U/mL
penicillin, and 100 µg/mL streptomycin.
HIF-1α +/+ fibroblasts were obtained from
C57 B mice with wild-type, normal, or
knockout HIF-1α gene (9) and were main-
tained in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine
serum, 100 U/mL penicillin, and 100 µg/mL
streptomycin. All cells were incubated at 37°C
in the presence of 5% of CO2 in air. Cells
were rendered hypoxic in a chamber with a
gas mixture of 0.5% of O2, 5% of CO2 bal-
anced with N2 at 37°C. The level of oxygen in
a chamber was verified using a gas monitor
(SKC, Inc., Eighty Four, PA, USA).
Northern Blot Analysis
Total RNA was extracted from cells
immediately after exposure using an ULTRA-
SPEC RNA isolation system (Biotecx,
Houston, TX, USA), and the RNA was elec-
trophoresed (15 µg of total RNA/lane) in
1.0% agarose/formaldehyde gels. Probes were
labeled with [α -32P]dcTP using the Random
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Cap43 is a protein whose RNA is induced under conditions of severe hypoxia or prolonged
elevations of intracellular calcium. Additionally, Ni and Co also induce Cap43 because they pro-
duce a state of hypoxia in cells. Cap43 protein is expressed at low levels in normal tissues; how-
ever, in a variety of cancers, including lung, brain, melanoma, liver, prostate, breast, and renal
cancers, Cap43 protein is overexpressed in cancer cells. The low level of expression of Cap43 in
some normal tissues compared with their cancerous counterparts, combined with the high stabil-
ity of Cap43 protein and mRNA, makes the Cap43 gene a new, important cancer marker. We
hypothesize that the mechanism of Cap43 overexpression in cancer cells involves a state of
hypoxia characteristic of cancer cells where the Cap43 protein becomes a signature for this
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Primed DNA Labeling Kit (Boehringer
Mannheim, Indianapolis, IN, USA).
Western Blot Analysis
Cells were lysed in TNES buffer [50 mM Tris-
HCl (pH 7.5), 2 mM EDTA, 100 mM NaCl,
1 mM sodium orthovanadate, and 1% NP40
containing protease inhibitors (20 µg/mL
aprotinin, 20 µg/mL leupeptin, and 1 mM
phenylmethylsulfonyl ﬂuoride)]. The detection
of HIF-1α was as described previously (10).
Results
We have reported the cloning of a human
gene, Cap43, that was significantly induced
by nickel in A549, HTE, Calu-1, WI38, and
HOS (human osteosarcoma) cells (3). The
basal level of Cap43 expression was very low
in these cells, and it was induced by nickel
within 4–6 hr. Exposure of cells to hypoxia
(0.5% oxygen) induced Cap43 mRNA
within 4 hr, and levels continued to increase
up to 18 hr (Figure 1). The induction of this
gene by hypoxia continued to increase up to
30 hr, and as with nickel, the induction
remained high for at least 60 hr (not shown).
We had previously tested numerous stress
conditions such as reducing or oxidative stress
and heat shock; however, these conditions did
not induce Cap43 expression (10). The expres-
sion of Cap43 in response to nickel or hypoxia
in terms of the kinetics or n-fold of induction
was very similar, suggesting that a common
signaling pathway might be activated by both
nickel and hypoxia (Figure 1A, B) (3).
GAPDH, a gene known to be induced by
hypoxia, was also induced by 1 mM nickel or
300 µM cobalt chloride in A549 cells
(Figure 1B). The latter metal was also found to
induce Cap43. It was conceivable that hypoxia
represented a physiological inducer for the
Cap43 gene, and nickel stimulated Cap43
expression by imitating hypoxic conditions in
cells. The activation of HIF-1 transcription
factor is an important part of the molecular
response to hypoxia. To determine whether
the HIF-1 transcription factor was involved in
Cap43 gene expression, we analyzed the time
course of accumulation of HIF-1α in response
to hypoxia in A549 cells. HIF-1α was an
inducible subunit of HIF-1 transcription fac-
tor, and its accumulation correlated with the
activation of HIF-1 transcriptional activity
(11). A signiﬁcant amount of HIF-1α protein
was found in A549 cells after their exposure to
hypoxia (Figure 1C). Similarly, accumulation
of HIF-1α was observed in nickel-treated
A549 cells (10). To confirm that the HIF-1
transcription factor was involved in the Cap43
gene expression, we compared the Cap43 gene
expression in response to hypoxia, as well as
nickel and cobalt, in mouse fibroblasts that
originated from normal or HIF-1α knockout
mice. An induction of Cap43 by hypoxia was
found in fibroblasts that originated from
HIF-1α +/+ mice but not in those from
HIF-1α –/– mice (Figure 2A). Similarly, the
induction of Cap43 gene expression by nickel
or cobalt was also observed in ﬁbroblasts that
originated from HIF-1α +/+ mice but not in
those from HIF-1α –/– mice (Figure 2A). The
induction of another gene, GAPDH, by nickel,
cobalt, or hypoxia was also found in ﬁbroblasts
that originated from HIF-1α +/+ mice and not
in cells from HIF-1α –/– mice (Figure 2B).
These data suggest that the induction of gene
expression in response to either hypoxia or
metals requires the HIF-1 transcription factor.
We examined, by immunohistochemical
staining, the levels of Cap43 protein in a vari-
ety of human normal and cancer tissues. An
antibody was raised against a 30-amino acid
sequence at the C-terminal end of the Cap43
protein, which includes three 10-amino-acid
repeats. Figure 3 shows a variety of normal and
cancer cells stained with this Cap43 polyclonal
antibody. To understand whether elevations of
Cap43 correlated with a state of hypoxia, we
also stained tissues with an antibody to HIF-
1α (Figure 4). Figure 3A shows lung cancer
tumor cells, as well as surrounding normal tis-
sue. Cap43 antibody preferentially stains
malignant lung cancer cells, including both
non–small-cell and small-cell types. Figure 4D
and E shows normal lung tissue such as the
bronchus or the alveolus have very low expres-
sion of Cap43 compared with the cancer cells
(Figure 3). As shown in Table 1, all 10 of the
lung cancer tissues from 10 different patients
had elevations of Cap43 in the cancer cells,
whereas surrounding normal cells did not. In
contrast, HIF-1α was present in both normal
and lung cancer cells (Figure 5A, Table 1). As
shown in Figure 5A, HIF-1α was present at
higher levels in some cancer cells but not to the
extent that was found with Cap43. Cap43
stains the nucleus as well as the cytoplasm of
the neoplastic cells but nonneoplastic lung cells
such as the bronchus and alveolus stain very
poorly with Cap43 antibody (Figure 4D, E).
Cap43 protein is generally found at low levels
in most normal tissues, with the exception of
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Figure 1. Induction of Cap43 and GAPDH gene
expression in A549 cells by metals or hypoxia.
(A) Induction of Cap43 gene expression by hypoxia.
A549 cells were exposed to hypoxia (0.5% O2) for
the time periods indicated. Fifteen micrograms of
total RNA were isolated and subjected to Northern
blot analysis. The blot was ﬁrst hybridized with the
Cap43 probe (top); then the membrane was
stripped and rehybridized with β -actin (bottom).
(B) Induction of GAPDH gene expression in A549
cells by metals. A549 cells were exposed to 1 mM
NiCl2 or 300 µM CoCl2 for 20 hr. Fifteen micrograms
of total RNA were isolated and subjected to a
Northern blot analysis. The blot was ﬁrst hybridized
with the GAPDH probe (right); then the membrane
was stripped and rehybridized with β -actin (left).
(C) Time course of HIF-1α induction by hypoxia in
A549 cells. A549 cells were exposed to hypoxic
conditions (0.5% O2) for the time periods indicated.
Forty micrograms of nuclear extracts were sub-
jected to Western blot analysis.
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Figure 2. HIF-1 transcription factor was involved in
nickel-induced gene expression. (A) Induction of
Cap43 gene expression in mouse HIF-1α +/+ or HIF-
1α –/– fibroblasts by nickel or hypoxic conditions.
Cells originating from HIF-1α +/+ or HIF-1α –/– mice
were exposed to hypoxia (0.5% O2), NiCl2, or CoCl2
for 20 hr. Fifteen micrograms of total RNA were iso-
lated and subjected to a Northern blot analysis. (B)
Induction of GAPDH gene expression in HIF-1α +/+
or HIF-1α –/– mouse ﬁbroblasts by nickel or hypoxic
conditions. GAPDH gene expression was assessed
by Northern blot analysis. Bottom panels show
loading control.Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 5 | OCTOBER 2002 785
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Lung, adenocarcinoma Brain, normal Brain, glioblastoma
Brain, glioblastoma Melanoma Prostate, hyperplastic
Prostate, carcinoma Breast, carcinoma Kidney, normal
Kidney, carcinoma Colon, normal Colon, adenoma
Skin, nevus
Figure 3. Tissue staining with a polyclonal antibody to Cap43. Various normal and cancerous
tissues were stained with a polyclonal antibody to Cap43 as described in ”Materials and
Methods.” The nature of the tissue stained is indicated in each panel A–M.some higher expression in the distal and proxi-
mal convoluted tubules of the kidney (Figure
3I). The distal and proximal convoluted
tubules of the kidney also express HIF-1α
(Figure 5C). There is also expression of Cap43
protein in colon mucosa, colon smooth mus-
cle, and normal prostate, as well as some
expression in normal breast cells and in normal
lung tissue (Figures 3, 4). However, the expres-
sion of Cap43 in the cancer cells of these tis-
sues is considerably higher or very different, as
shown in Figure 3. Figure 3B shows a low level
of Cap43 protein expression in normal human
brain. Cells in the brain slices that we exam-
ined express low levels of Cap43 protein
(Table 1). Figure 3C is a low-magnification
view of a malignant human glioblastoma multi-
form; Figure 3D shows a higher magniﬁcation
of this brain tumor and surrounding normal
tissue. Cap43 antibody preferential stains the
tumor cells adjacent to the necrotic areas. The
staining of Cap43 in these cells is localized to
the membrane. In this particular case, HIF-1α
antibody also similarly stained the same areas
as did Cap43 antibody (Figure 5G), suggesting
that the induction of HIF-1α by hypoxia may
be responsible for the elevation of Cap43 in
the malignant brain cells (Figures 3C, D, 5G).
Table 1 shows that both for astrocytomas and
for hemangioblastoma tumors, there is intense
staining for both Cap43 and HIF-1α in several
different patients.
Figure 3E shows a malignant melanoma
with intense Cap43 staining in the cancer cells,
whereas normal skin has little Cap43 staining
(Figure 3M). In contrast, melanoma has little
staining for HIF-1α (Figure 5B). Figure 3F
shows hyperplastic prostatic epithelial cells that
stained positively for Cap43. Figure 3G shows
a low magnification of Cap43 staining of a
high-histological-grade prostatic adenocarci-
noma. Cap43 staining is intense in the tumor
cells and very different from the normal cells.
Figure 3H as well as Figure 4A–C shows that
normal breast cells stain poorly for Cap43 but
that the cells of invasive ductal carcinoma in
situ stain intensely for Cap43. Table 1 shows
the total number of patients examined for nor-
mal breast (0 of 6) and breast cancer. In con-
trast to Cap43 (4 of 4), HIF-1α (2 of 4) is not
as high in breast cancer cells as is Cap43. The
distribution of Cap43 in breast cancer cells
seems localized to the membrane predomi-
nantly and focally to the cytoplasm. The stain-
ing is consistent for either histological grade of
breast cancer.
Figure 3I shows the staining of the
proximal and distal convoluted tubules of
the normal kidney. There is no staining for
HIF-1α and Cap43 in the glomerulus; how-
ever, there was differential staining of the
tubular system for both Cap43 (Figure 3I)
and HIF-1α (Figure 5C). The proximal
tubules appear to have polarized membrane
staining, whereas the distal convoluted
tubules have homogeneous cytoplasmic
staining for Cap43 (Figure 3I). Figure 3J
shows a renal cancer (renal cell carcinoma)
demonstrating diffused cytoplasmic staining
for Cap43. Figure 3K shows a normal colon,
and Figure 3L shows an adenoma of the
colon. There is less staining of Cap43 in the
colon cancer cells compared with the normal
cells. The lower levels of Cap43 protein in
colon cancer have been reported by other
groups of investigators (1). Similarly,
HIF-1α was higher in normal colon (Figure
5F) compared with colon cancer (Figure
5E). We have also stained many of the same
tumor tissues with CYP1B1 that were
stained with Cap43 and HIF-1α . However,
as reported by another group (12), CYP1B1
is widely expressed at higher levels in normal
cells and thus is not a good cancer marker.
It should be noted, as shown in Figure 6,
that the antibodies used to stain tissues for
Cap43 and HIF-1α stain only one protein
with Western blot analysis.
Discussion
There have been very few proteins that exhibit
cancer-speciﬁc overexpression. One promising
cancer-specific marker has been CYP1B1,
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Table 1. Presence of Cap43 and HIF-α proteins in
various normal and malignant tissues.
Cap43 HIF-α
Normal lung 0/10 10/10
Lung cancer 10/10 10/10
Normal liver 0/3 0/3
Liver cancer 3/3 n.d.
Normal breast 0/6 0/6
Breast cancer 4/4 2/4
Lymphocytes (tonsils) 0/3 0/3
Smooth muscle 0/30 10/30
Smooth muscle tumor 4/6 n.d.
Normal brain 0/3 0/3
Brain cancer astrocytoma 7/7 7/7
Brain cancer hemangioblastoma 3/3 3/3
Renal cancer 22/22 0/3
Normal and cancerous tissues were stained with either
Cap43 or HIF-1α antibody as described in “Materials and
Methods.” Data are from single tissue samples from indi-
vidual patients. Low expression levels or background
expression of normal breast and lung cells (as shown in
Figure 4) was counted as 0.
A B C
D E
Figure 4. Normal tissue staining with a
polyclonal antibody to Cap43. Normal breast
and lung tissue were stained with a poly-
clonal antibody to Cap43 as described in
”Materials and Methods.” (A–C) Normal
breast tissue at 4× , 10× , and 40× magnifica-
tion, respectively. (D,E) Bronchus and
alveolar tissue at 40× magniﬁcation.which was found by a group of investigators
to be overexpressed in a variety of cancer cells
(12). However, another group of investigators
was unable to repeat this finding and found
CYP1B1 to also be highly expressed in normal
tissue (13). Our results are in agreement with
this latter group. p53 mutations greatly
increased the half-life of the protein in cancer
cells, which may be a cancer-specific marker
for populations of cancer cells that have p53
mutations (14,15). Although p53 mutations
are common in many kinds of cancer, they are
not sufﬁciently high in incidence for p53 pro-
tein overexpression to be used as a cancer-spe-
cific marker. With the exception of colon
cancer, which tends to have decreased levels of
Cap43 for reasons that are unknown, most of
the other major cancers overexpress Cap43
protein. In some of these cancers, the reason
for the overexpression of Cap43 protein may
be the hypoxic conditions of the tumor cells or
adjacent tissues that overexpress HIF-1α ,
which induces Cap43. In fact, in some
instances HIF-1α was also elevated in the same
cancer cells in which Cap43 was overexpressed.
However, in other instances, HIF-1α does not
stain all the tumor cells that overexpress
Cap43, although consistently the antibody to
Cap43 protein stains the tumor cells. These
differences may be due to Cap43 protein
being considerably more stable than HIF-1α ,
and thus Cap43 may be a better signature for
hypoxic cells than HIF-1α . Another possible
explanation is that some of the Cap43 induc-
tion may be HIF-1 independent, as has
recently been shown for p27 induction by
hypoxia (16).
The remarkable overexpression of Cap43
protein makes it an extremely valuable
marker for cancer cells, and in fact, staining
with Cap43 antibody allows one in many
instances to identify cancer cells from normal
cells. There is also the possibility of Cap43
protein being present in serum, and it might
be elevated in patients who have cancer.
Thus, the elevation of Cap43 protein in
human serum may be used as a test for early
cancer detection. However, these studies have
not been conducted at the present time, and
future studies will address this problem.
Additionally, it may be possible to direct
therapy toward Cap43 protein with drugs
Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 5 | OCTOBER 2002 787
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Kidney, cancer Colon, normal Colon, adenocarcinoma
Figure 5. Tissue staining with a polyclonal antibody to HIF-1α . Various normal and
cancerous tissues were stained with a polyclonal antibody to HIF-1α as described in
”Materials and Methods.”
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Figure 6. Western blot of human cellular extract
stained with Cap43 and HIF-1α  antibody. Cap43
and HIF-1α were induced in human cells with
either hypoxia or NFi, and protein was separated
with sodium dodecyl sulfate–polyacrylamide gel
electrophoresis. Antibody staining was accom-
plished by Western blot transfer using a Cap43
antibody (A) or an HIF-1α antibody (B).that specifically destroy Cap43 protein.
Although the function of Cap43 protein is
unknown at the present time, its induction
by hypoxia and Ca2+ suggests that it could
play a pivotal function for cancer cell survival.
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